期刊文献+

ALT低于2倍正常值上限的慢性HBV感染者肝脏病理结果的预测因素分析 被引量:3

Analysis of predictors of liver injury stage in chronic HBV infection patients with ALT levels lower than 2 × ULN
下载PDF
导出
摘要 目的探索在ALT<2倍正常值上限(2×ULN)的慢性HBV感染人群中,一般临床指标对肝脏病理结果的预测作用。方法收集2009年1月至2013年6月新乡医学院第一附属医院收治的122例ALT<2×ULN的慢性HBV感染者,在超声引导下行肝穿刺活组织检查术,判断肝组织炎症活动度及纤维化程度,同期化验肝功能、乙型肝炎血清标志物、HBV DNA等指标,应用Logistic回归分析法探索该类患者的一般临床指标对其肝脏病理结果的预测作用。结果 122名患者中有明显炎症或纤维化(G≥2或S≥2)者共94例(77.0%),早期肝硬化者5例(4.1%)。G<2组与G≥2组相比,除HBV DNA外,其余各指标间差异均无统计学意义;S<2组与S≥2组相比,年龄、HBeAg、HBV DNA、AST、血小板差异均有统计学意义;Logistic回归分析提示,年龄、HBeAg和AST是肝脏明显纤维化(S≥2)的独立预测因子。结论对血清ALT<2×ULN的慢性HBV感染者,年龄>40岁、HBeAg阴性、AST>40U/L者应积极进行肝穿刺活组织检查术,必要时尽早抗病毒治疗。 Objective To investigate the role of various clinical parameters in predicting liver injury stage in patients with chronic hepatitis B virus( HBV) infection who had alanine aminotransferase( ALT) levels lower than 2 times the upper limit of normal( ULN). Methods Ultrasound- guided liver biopsy was performed in chronic HBV infection patients with ALT levels lower than 2 × ULN. The activity of inflammation and degree of fibrosis in liver tissues were assessed. Meanwhile,liver function,serum HBV markers,and HBV DNA were measured. The role of these clinical parameters in predicting liver injury stage was evaluated by logistic regression analysis. Results Among 122 patients,94( 77. 0%) had significant inflammation or fibrosis( G≥2 or S≥2),and 5( 4. 1%) had early cirrhosis. There was significant difference in HBV DNA between G ≥2 group and G 2 group,but other parameters showed no significant differences between the two groups. There were significant differences in age,HBeAg,HBV DNA,AST,and platelet count between S≥2 group and S〈2 group. The logistic regression analysis showed that age,HBeAg,and AST were independent predictors of significant liver fibrosis( S≥2). Conclusion Liver biopsy is necessary for chronic HBV infection patients with serum ALT levels of〈2 × ULN,aged over 40 years,negative for HBeAg,or with serum AST levels of 40 U /L.
出处 《临床肝胆病杂志》 CAS 2014年第9期895-898,共4页 Journal of Clinical Hepatology
基金 河南省卫生科技创新型人才工程资助项目
关键词 肝炎病毒 乙型 丙氨酸转氨酶 活组织检查 针吸 hepatitis B virus alanine transaminase biopsy needle
  • 相关文献

参考文献15

二级参考文献72

共引文献3271

同被引文献21

  • 1KIM HY, KIM CW, LEE CD, et al. Can " healthy" normal ala- nine aminotransferase levels identify the metabolically obese phenotype? Findings from the Korea national health and nutri- tion examination survey 2008-2010[J]. Dig Dis Sci, 2014, 59(6) : 1330 -1337.
  • 2WANG H, YAN R, ZHQU Y, et al. A scoring system for pre- dicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels [J]. J Clin Gastroenterol, 2015, 49(1 ) : 69 -75.
  • 3PUOTI C. How to manage HBeAg -negative chronic HBV in- fection with normal alanine aminotransferase levels in clinical oractice? [J]. EurJ Intern Med. 2013,24(2}, 100-103.
  • 4ISHAK KG. Pathologic features of chronic hepatitis. A review and update[J]. Am J Clin Pathol, 2000, 113(1): 40-55.
  • 5HOLOMAN J, GLASA J. EASL clinical practice guidelines[J]. J Hepatol, 2009, 51 (4) : 821 -822.
  • 6KIM HC, NAM CM, JEE SH, et al. Normal serum aminotrans- ferase concentration and risk of mortality from liver diseases; prospective cohort study[J]. BMJ, 2004, 328(7446) : 983.
  • 7DESMET VJ. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology1981, 1:431 -435][J]. J Hepatol, 2003, 38 (4): 382 -386.
  • 8潘峻岩,刘丽娜,石铭.慢性无症状HBV感染者前C区变异与肝脏病理的关系[J].临床肝胆病杂志,2008,24(2):126-126. 被引量:1
  • 9朱陇东,袁宏,陈琳.慢性无症状乙型肝炎病毒携带者肝组织病理及临床分析[J].临床肝胆病杂志,2010,26(6):633-634. 被引量:7
  • 10贾继东,李兰娟.慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志,2011,19(1):13-24. 被引量:3212

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部